Rates of infection and bleeding are not increased in patients (Pts) with MDS treated with azacitidine (AZA) compared with best supportive care (BSC)

Journal article

V Santini, L Silverman, J Seymour, P Fenaux, G Mufti, E Hellstrom-Lindberg, G Sanz, C Finelli, J Backstom, D McKenzie, C Beach

LEUKEMIA RESEARCH | PERGAMON-ELSEVIER SCIENCE LTD | Published : 2009